In a liquid biopsy approach, many studies have proven that SEPT9 can distinguish CRC patients from healthy controls and thus suggested its potential to use this gene as a diagnostic biomarker [185,186,187]. Here, SEPTIN9 is linked to colorectal carcinoma.